Inclusion criteria (ANVISA) [Regulatives / Guidelines]

posted by patel_prakash79  – India, 2009-12-03 12:07 (5255 d 16:29 ago) – Posting: # 4412
Views: 8,428

Dear HS,

There is a guidance for window period of study participation between two studies. however, it is applicable only to the studies to be carried out in Brazil as per my knowledge. The below is the details of respective guidance available on ANVISA website. It is available in Portuguese.

Article 7 is hereby established the minimum 6 (six) months from the date of the last hospitalization in a study and participation in a new study of bioavailability and bioequivalence studies for the same volunteer.

Referece: ANVISA - RDC No. 34 OF 3 JUNE 2008. Establishing the Information System for the Study of pharmaceutical equivalence and bioequivalence - SINEB and the National Registry of Volunteers in Studies Bioequivalence - CNVB

With regards,
Prakash


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,657 registered users;
70 visitors (0 registered, 70 guests [including 5 identified bots]).
Forum time: 05:36 CEST (Europe/Vienna)

So far as I can remember,
there is not one word in the Gospels
in praise of intelligence.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5